As quantum computing moves from theory to application, its potential to transform drug discovery is becoming increasingly tangible. In this session, Sumit Kapur, CEO of Zapata Quantum, explores how hybrid quantum-classical approaches are accelerating the design of complex therapeutics and unlocking new possibilities in precision medicine. Building on peer-reviewed research published in Nature Biotechnology, Kapur will share how quantum-enabled methods are demonstrating real-world impact, including in the design of KRAS inhibitors. These approaches navigate molecular complexity beyond the limits of traditional computing, enabling faster discovery and more targeted therapies.
Speakers
Who you'll hear from
Start Date
End Date
Location
eMerge HEALTH Stage
Topics
Quantum, Healthtech
